D. Western Therapeutics Institute, Inc. (4576.T)
JPY 106.0
(1.92%)
JPY 106.0
(1.92%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 87.86 Million JPY | 10.92% |
| 2022 | 79.21 Million JPY | -10.39% |
| 2021 | 88.39 Million JPY | 51.57% |
| 2020 | 58.32 Million JPY | -1.76% |
| 2019 | 59.36 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 103.52 Million JPY | 22.02% |
| 2024 Q1 | 84.84 Million JPY | -3.44% |
| 2023 Q4 | 87.86 Million JPY | 2.41% |
| 2023 FY | 87.86 Million JPY | 10.92% |
| 2023 Q3 | 85.79 Million JPY | -39.12% |
| 2023 Q2 | 140.92 Million JPY | 80.35% |
| 2023 Q1 | 78.13 Million JPY | -1.09% |
| 2022 Q4 | 79 Million JPY | 9.73% |
| 2022 Q3 | 71.99 Million JPY | 0.0% |
| 2022 FY | 79.21 Million JPY | -10.39% |
| 2021 FY | 88.39 Million JPY | 51.57% |
| 2020 FY | 58.32 Million JPY | -1.76% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 87.136% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -390.061% |
| GNI Group Ltd. | 2.33 Billion JPY | 96.23% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 96.056% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -30.204% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 92.161% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 15.136% |
| AnGes, Inc. | 1.61 Billion JPY | 94.562% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -18.735% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 96.973% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 72.706% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -47651.63% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 37.303% |
| CanBas Co., Ltd. | 728 Thousand JPY | -11969.093% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 40.609% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -37.057% |
| Kidswell Bio Corporation | 875.65 Million JPY | 89.966% |
| PeptiDream Inc. | 2.4 Billion JPY | 96.345% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -1544.759% |
| Ribomic Inc. | 2.27 Million JPY | -3763.808% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -8786299900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -144.064% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -202.976% |
| CellSource Co., Ltd. | 305.92 Million JPY | 71.28% |
| FunPep Company Limited | 25.54 Million JPY | -244.008% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 75.866% |
| Stella Pharma Corporation | 1.11 Billion JPY | 92.129% |
| TMS Co., Ltd. | 50.02 Million JPY | -75.638% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -320.377% |
| Cuorips Inc. | 1.04 Million JPY | -8324.065% |
| K Pharma,Inc. | 10.79 Million JPY | -713.999% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.259% |
| ReproCELL Incorporated | 248.14 Million JPY | 64.591% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 80.5% |
| StemCell Institute Inc. | 42.26 Million JPY | -107.901% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 61.559% |
| CellSeed Inc. | 46.19 Million JPY | -90.217% |